FUJIFILM Irvine Scientific Acquires Exclusive License for Artificial Intelligence for IVF
SANTA ANA, Calif., June 22, 2022: FUJIFILM Irvine Scientific,
Inc., a world leader in the innovation, development, and manufacture of
cell culture media and assisted reproductive technologies (ART), today
announced it has exclusively licensed the intellectual property relating
to artificial intelligence (AI) for image-based evaluation of human
embryos to improve in-vitro fertilization (IVF) success rates. The
technology was developed and patented jointly by investigators from
Brigham and Women’s Hospital and Massachusetts General Hospital with
expertise in artificial intelligence, biomedical engineering and IVF.
Terms of the deal were not disclosed.
More info >> |